The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma
Open Access
- 17 May 2022
- Vol. 10 (5), 793
- https://doi.org/10.3390/vaccines10050793
Abstract
Over 1.5 million preventable new hepatitis B infections continue to occur each year and there are an estimated 296 million people living with chronic hepatitis B infection worldwide, resulting in more than 820,000 deaths annually due to liver cirrhosis and hepatocellular carcinoma (HCC). Hepatitis B vaccination remains the cornerstone of public health policy to prevent HCC and a vital component of the global hepatitis B elimination response. The WHO has set a 90% vaccination target to achieve hepatitis B elimination by 2030; however, there is wide variability in reported birth dose coverage, with global coverage at only 42%. In this review, we outline the global trends in hepatitis B vaccination coverage and the impact of hepatitis B vaccination on HCC incidence and discuss the challenges and enabling factors for achieving WHO 2030 hepatitis B vaccination coverage targets.This publication has 93 references indexed in Scilit:
- 20-Years of Population-Based Cancer Registration in Hepatitis B and Liver Cancer Prevention in The Gambia, West AfricaPLOS ONE, 2013
- Gaps in the prevention of perinatal transmission of hepatitis B virus between recommendations and routine practices in a highly endemic region: a provincial population-based study in ChinaBMC Infectious Diseases, 2012
- The association between travel time to health facilities and childhood vaccine coverage in rural Ethiopia. A community based cross sectional studyBMC Public Health, 2012
- Vaccination coverage and timeliness in three South African areas: a prospective studyBMC Public Health, 2011
- Preventing primary liver cancer: the HBV vaccination project in the Gambia (West Africa)Environmental Health, 2011
- Probabilistic cost-effectiveness analysis of the long-term effect of universal hepatitis B vaccination: An experience from Taiwan with high hepatitis B virus infection and Hepatitis B e Antigen positive prevalenceVaccine, 2009
- High impact of migration on the prevalence of chronic hepatitis B in the NetherlandsEuropean Journal of Gastroenterology & Hepatology, 2008
- Hepatitis B immunization and hepatocellular carcinoma: The Gambia hepatitis Intervention StudyJournal of Medical Virology, 2002
- Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization ProgramThe Journal of Infectious Diseases, 2000
- Effect of anatomic injection site, age and smoking on the immune response to hepatitis B vaccinationVaccine, 1989